Dexmedetomidine sedation after stroke clot removal
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 4 study tests whether using a specific calming medicine (dexmedetomidine) for a longer period after a successful clot-removal procedure helps people do better in the long term. It may help improve outcomes after ischemic stroke where the clot is successfully treated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an acute ischemic stroke (a blocked blood vessel) and underwent mechanical thrombectomy.
- Clot-removal result was good (blood flow score mTICI 2b or 3).
- Your current symptoms score was between 2 and 25 (NIHSS).
- Before this stroke, you could function well enough (mRS before stroke was under 3).
- Your stroke area did not bleed in the last 6 weeks, and you did not have a stent placed in the responsible vessel before.
- You must be able to have the procedure with local anesthesia/sedation, and you can sign consent (you or a legal representative).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single dose of ketamine, given within 24 hours of a stroke, can reduce brain damage and improve recovery. It is designed for people who had a recent ischemic stroke and who are not eligible for standard clot-busting or clot-removal treatments.
This trial tests if giving a steroid (methylprednisolone) directly into the brain artery after successful clot removal improves recovery. It is for people who had a large stroke in the front part of the brain and got the clot out within 24 hours.
This trial looks at whether a medication called dexmedetomidine can reduce “postoperative delirium,” a temporary period of confusion after awake brain surgery. If you have the type of surgery the study focuses on, this could help your recovery and mental clarity afterward.
This study tests whether a combination of two medicines (dexmedetomidine and esketamine) and a gentle brain stimulation technique (tDCS) can help prevent confusion or memory problems that sometimes happen after surgery in older adults.
This study looks at combining two treatments—a sedative drug and a mild brain stimulation technique—to see if they can help reduce confusion or memory problems that can happen after surgery in older people. It might help you if you have mild cognitive issues before your surgery.
This trial tests a specific sedation approach, along with support during the procedure, for people having emergency clot removal (mechanical thrombectomy) for a certain type of acute ischemic stroke. It may help make the procedure safer and more effective by improving how patients are managed during endovascular treatment.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.